在 C & EN , Apr ,27 .2009 上,登了一篇题为 "Back from China". 它的付标题为 "Manufacturing of Pharmaceutical chemicals and related goods is starting to trickle back to the U.S."
文中从二个具体例子,一是Pfizer ,二是 Labware CP Lab,展开论述,详见原文.
虽然提出许多情况,但我认为较中心的要点,是质量控制,不仅产品,而且环境,包括所有环节. 所以我用标题讲法,供参考.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment